Eagle Biologics Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $78.2M
Latest Deal Amount

Eagle Biologics General Information

Description

Operator of a biopharmaceutical agency intended to develop innovative protein formulation. The company's biopharmaceutical agency produces high-concentration drugs and related products with low viscosity, suitable for small-volume subcutaneous injection, enabling clients to avail improved access to highly viscous protein therapeutics.

Contact Information

Website
www.arsiarx.com
Formerly Known As
Arsia Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Acquirer
Eagle Pharmaceuticals
Primary Office
  • Kendall Square
  • Cambridge, MA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Eagle Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 11-Nov-2016 $78.2M 000.00 Completed Generating Revenue
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view Eagle Biologics’s complete valuation and funding history, request access »

Eagle Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biopharmaceutical agency intended to develop innovative protein formulation. The company's biopharmaceutic
Biotechnology
Cambridge, MA
00.00 0000-00-00
000000&0

000000 0

oluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pr
0000000000000
Woburn, MA
00000 00000

000000

p ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000000
Cambridge, United Kingdom
000 As of 0000
0000
0000000 0000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eagle Biologics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ReForm Biologics Venture Capital-Backed Woburn, MA 00000 00000
000000 Private Equity-Backed Cambridge, United Kingdom 000 0000 0000000 0000 0000
00000 000000000000 Venture Capital-Backed Oxfordshire, United Kingdom 00 00000 0000000000 0 00000
000000000 Venture Capital-Backed Newcastle upon Tyne, United Kingdom 00 00000 0000000000 0 00000
00000 Venture Capital-Backed Cambridge, United Kingdom 000 00000 0000000000 0 00000
You’re viewing 5 of 10 competitors. Get the full list »

Eagle Biologics Executive Team (5)

Name Title Board Seat Contact Info
Kevin Love Director, Business Development & Operations
Charles Wescott Ph.D Vice President of Research & Development
Alexander Klibanov Co-Founder
Robert Langer Ph.D Co-Founder
To view Eagle Biologics’s complete executive team members history, request access »

Eagle Biologics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
JLABS Accelerator/Incubator 000 0000 000000 0
Polaris Partners Venture Capital Minority 000 0000 000000 0
To view Eagle Biologics’s complete investors history, request access »

Ready to get started?

Request a free trial